Edaravone Injection By Medonco Pharma

Medavon (Edaravone
Injection)

Edaravone Injection is a neuroprotective agent
primarily used for treating Amyotrophic Lateral Sclerosis (ALS) and in
some cases, acute ischemic stroke. It helps reduce oxidative stress,
which can damage neurons.

Uses

* Amyotrophic
Lateral Sclerosis (ALS) slows functional decline

*Acute
Ischemic Stroke (in some countries) to limit brain damage if given
early

* Key Benefits

*Protects
neurons from oxidative damage

* Slows
disease progression in ALS

* May
improve motor functions over time

* Reduces
inflammation in the brain and nerves

Mechanism of Action

Edaravone acts as a free radical scavenger. It:

* Neutralizes
harmful oxygen free radicals

* Prevents
lipid peroxidation and neuronal damage

* Reduces
oxidative stress in nerve cells

Dosage &
Administration

* Administered
via intravenous (IV) infusion

* Common
ALS regimen:

* 60
mg once daily for 14 days, followed by 14 days drug-free

* Then,
10-day infusion cycles in each 28-day period

* Infusion
time: ~60 minutes

Only under medical supervision in a hospital or
clinic.

Common Side Effects

* Bruising
or pain at injection site

* Headache

* Gait
disturbance

* Skin
rash

* Breathing
difficulties (rare)

Monitoring

* Liver
function tests

* Watch
for hypersensitivity or anaphylaxis

* Regular
neurological evaluation for ALS progression

Precautions

* Caution
in patients with renal impairment

* Not
recommended during pregnancy or breastfeeding unless clearly needed

* Use
with care in patients with a history of allergies

Drug Interactions

* Limited
known interactions

* Inform
your doctor if using other neuroprotective agents or immunosuppressants

Tips for Patients

* Report
any breathing difficulty or skin reactions immediately

* Ensure
the full infusion cycle is completed as prescribed

* Keep
follow-up appointments for progress assessment

* Not
a cure used to slow progression of ALS